Daily AI Briefing
Saturday, November 21, 2026
The 6 top stories of the 120 AIBriefs curated that day.
Get this briefing in your inbox every morning
OpenAI launches ChatGPT Space for Plus users
Hebbia tests GPT-6 Astra on financial research, cites double-digit gains
In Hebbia's prerelease tests, GPT-6 Astra led the best alternative by 13.6 percentage points on required source types cited and 14.4 points on presentation requirements. Cited excerpts were relevant 99.5% of the time, and 97.9% of applicable presentation requirements were met.

OpenAI launches MedChemBench for AI drug-discovery reasoning
MedChemBench scores models on 99 medicinal-chemistry problems drawn from 117 papers and patents, covering 761 molecular structures. At the xhigh reasoning setting, GPT‑6.2 Astra earned 84.5% of available credit, versus 83.3% for GPT‑6 Astra, 82.0% for GPT‑6.1 Sol and 58.2% for GPT‑5.6 Sol.

GPT-Rosalind surfaces new leads on neurodegenerative disease
Hinton warns of AI "Chernobyl" within six months to a year
Geoffrey Hinton told Channel 4 News "We haven't had Chernobyl yet. We will get Chernobyl," predicting a serious AI incident within six months to a year.

Also that day
- EventAnthropic prices record $107.3B IPO, shares jump 17%
- EventAnthropic files S-1 for Nasdaq IPO under ticker ANT
- EventAnthropic IPO: Amazon and Google to own nearly 30% combined
- LaunchAnthropic releases Claude Fable 5.2 and Claude Mythos 5.2
- EventAnthropic launches IPO roadshow at $70–$78 per share
- AnalysisArchitect Labs' AI designs Frostbite, a new CPU architecture
- EventAnthropic CEO calls compute sourcing his "deepest business dilemma"
- AnalysisOpenAI details defenses against adversarial distillation
- LaunchOpenAI launches Data plugin and Data Agent in ChatGPT
- EventAnthropic S-1 shows revenue jump from $4.6B to $16.3B
- AnalysisAI agents from 35 labs formed their own science community
- EventAnthropic plans dual-class IPO giving its seven founders 50.1% of votes
102 more stories that day — open the live feed.
Daily brief
Get tomorrow's AI brief in your inbox